Keeley-Teton Advisors, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 5 filers reported holding HAEMONETICS CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Keeley-Teton Advisors, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$569,729
+5.2%
6,3600.0%0.08%
+15.9%
Q2 2023$541,490
+2.9%
6,3600.0%0.07%
+6.2%
Q1 2023$526,290
+14.2%
6,360
+8.5%
0.06%
+14.0%
Q4 2022$460,889
+41.4%
5,860
+33.2%
0.06%
+26.7%
Q3 2022$326,000
+13.6%
4,4000.0%0.04%
+25.0%
Q2 2022$287,000
+3.2%
4,4000.0%0.04%
+24.1%
Q1 2022$278,0004,4000.03%
Other shareholders
HAEMONETICS CORP shareholders Q4 2023
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders